Overview

Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The study evaluates the efficacy and safety of using ketorolac as a nasal spray for the acute treatment of migraine.
Phase:
Phase 2
Details
Lead Sponsor:
Egalet Ltd
Treatments:
Ketorolac
Ketorolac Tromethamine